Compare with DEVRIA INTER - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GENERIC PHARMASEC vs CAMEX - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GENERIC PHARMASEC CAMEX GENERIC PHARMASEC/
CAMEX
 
P/E (TTM) x 90.3 27.4 329.6% View Chart
P/BV x 9.0 0.9 994.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 GENERIC PHARMASEC   CAMEX
EQUITY SHARE DATA
    GENERIC PHARMASEC
Mar-21
CAMEX
Mar-21
GENERIC PHARMASEC/
CAMEX
5-Yr Chart
Click to enlarge
High Rs1723 71.2%   
Low Rs710 73.1%   
Sales per share (Unadj.) Rs0.8147.1 0.5%  
Earnings per share (Unadj.) Rs01.3 3.4%  
Cash flow per share (Unadj.) Rs02.3 2.0%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs0.733.2 2.2%  
Shares outstanding (eoy) m276.8610.21 2,711.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x15.60.1 13,720.4%   
Avg P/E ratio x263.512.5 2,104.3%  
P/CF ratio (eoy) x260.97.4 3,546.4%  
Price / Book Value ratio x16.00.5 3,197.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,314170 1,946.8%   
No. of employees `000NANA-   
Total wages/salary Rs m235 5.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2131,502 14.2%  
Other income Rs m35 65.2%   
Total revenues Rs m2161,507 14.4%   
Gross profit Rs m1229 40.8%  
Depreciation Rs m010 1.3%   
Interest Rs m07 0.0%   
Profit before tax Rs m1518 84.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m34 58.5%   
Profit after tax Rs m1314 92.5%  
Gross profit margin %5.62.0 287.2%  
Effective tax rate %16.724.1 69.3%   
Net profit margin %5.90.9 651.9%  
BALANCE SHEET DATA
Current assets Rs m268723 37.1%   
Current liabilities Rs m72391 18.3%   
Net working cap to sales %92.122.1 417.0%  
Current ratio x3.71.8 202.4%  
Inventory Days Days1481 12,018.6%  
Debtors Days Days128,898,635102,018,813 126.3%  
Net fixed assets Rs m1085 12.2%   
Share capital Rs m277102 271.2%   
"Free" reserves Rs m-70237 -29.6%   
Net worth Rs m207339 60.9%   
Long term debt Rs m068 0.0%   
Total assets Rs m278807 34.5%  
Interest coverage xNM3.6-  
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.81.9 41.2%   
Return on assets %4.52.5 178.2%  
Return on equity %6.14.0 151.9%  
Return on capital %7.36.1 120.1%  
Exports to sales %013.1 0.0%   
Imports to sales %020.9 0.0%   
Exports (fob) Rs mNA196 0.0%   
Imports (cif) Rs mNA314 0.0%   
Fx inflow Rs m0199 0.0%   
Fx outflow Rs m0315 0.0%   
Net fx Rs m0-116 0.0%   
CASH FLOW
From Operations Rs m-21-143 14.9%  
From Investments Rs m-142 -570.9%  
From Financial Activity Rs m45141 32.0%  
Net Cashflow Rs m100 -2,122.2%  

Share Holding

Indian Promoters % 0.0 70.7 -  
Foreign collaborators % 60.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 29.4 136.4%  
Shareholders   17,121 3,214 532.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GENERIC PHARMASEC With:   SHREYAS INTE  SUDARSHAN CHEMICAL  JAYS.DYESTUF  VIPUL DYE CHEM  PODDAR PIGM.  



Today's Market

Sensex Ends 153 Points Higher; Kotak Mahindra Bank & HCL Tech Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally higher.

Related Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GENERIC PHARMASEC SHARE PRICE


Nov 29, 2021 (Close)

TRACK GENERIC PHARMASEC

  • Track your investment in GENERIC PHARMASEC with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GENERIC PHARMASEC

GENERIC PHARMASEC - SHREE PUSHKAR CHEMICALS COMPARISON

COMPARE GENERIC PHARMASEC WITH

MARKET STATS